115 related articles for article (PubMed ID: 7079196)
21. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
[TBL] [Abstract][Full Text] [Related]
22. The effect of a 5 alpha-reductase inhibitor on androgen physiology in the immature male rat.
George FW; Johnson L; Wilson JD
Endocrinology; 1989 Nov; 125(5):2434-8. PubMed ID: 2551651
[TBL] [Abstract][Full Text] [Related]
23. Effects of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one on steroidogenesis in gonads of rat fetuses.
Gangnerau MN; Rouiller V; Picon R
Gen Pharmacol; 1992 Sep; 23(5):823-6. PubMed ID: 1330804
[TBL] [Abstract][Full Text] [Related]
24. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
Ghusn HF; Shao TC; Klima M; Cunningham GR
J Androl; 1991; 12(5):315-22. PubMed ID: 1765567
[TBL] [Abstract][Full Text] [Related]
25. The effects of diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide (4-MA) and (4R)-5,10-SECO-19-norpregna-4,5-diene-3,10,20-trione (SECO) on androgen biosynthesis in the rat testis and epididymis.
Cooke GM; Robaire B
J Steroid Biochem; 1986 Apr; 24(4):877-86. PubMed ID: 3702462
[TBL] [Abstract][Full Text] [Related]
26. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
[TBL] [Abstract][Full Text] [Related]
28. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.
Hirosumi J; Nakayama O; Chida N; Inami M; Fagan T; Sawada K; Shigematsu S; Kojo H; Notsu Y; Okuhara M
J Steroid Biochem Mol Biol; 1995 Apr; 52(4):365-73. PubMed ID: 7734405
[TBL] [Abstract][Full Text] [Related]
29. Effects of 4-MA, a potent inhibitor of 5 alpha-reductase, on 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in guinea pig adrenals.
Perron S; Bélanger A
Steroids; 1994 Jun; 59(6):371-6. PubMed ID: 7940615
[TBL] [Abstract][Full Text] [Related]
30. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors.
Toomey RE; Goode RL; Petrow V; Neubauer BL
Prostate; 1991; 19(1):63-72. PubMed ID: 1876537
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
32. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
[TBL] [Abstract][Full Text] [Related]
33. Effects of an anti-androgen and 5 alpha-reductase inhibitors on estrus duration in the cycling female rat.
Erskine MS
Physiol Behav; 1983 Apr; 30(4):519-24. PubMed ID: 6683842
[TBL] [Abstract][Full Text] [Related]
34. CGP 53153: a new potent inhibitor of 5alpha-reductase.
Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hirsutism with 5 alpha-reductase inhibitors.
Brooks JR
Clin Endocrinol Metab; 1986 May; 15(2):391-405. PubMed ID: 3521959
[TBL] [Abstract][Full Text] [Related]
36. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of steroid 5 alpha-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450.
Sonderfan AJ; Parkinson A
Arch Biochem Biophys; 1988 Aug; 265(1):208-18. PubMed ID: 3415243
[TBL] [Abstract][Full Text] [Related]
38. Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Juniewicz PE; Barbolt TA; Egy MA; Frenette G; Dube JY; Tremblay RR
Prostate; 1990; 17(2):101-11. PubMed ID: 2169047
[TBL] [Abstract][Full Text] [Related]
39. The effect of 4MA, a potent inhibitor of 5 alpha-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice.
Andriole GL; Rittmaster RS; Loriaux DL; Kish ML; Linehan WM
Prostate; 1987; 10(3):189-97. PubMed ID: 3588410
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of 5 alpha-reductase activity impairs the testosterone-dependent restoration of spermiogenesis in adult rats.
O'Donnell L; Stanton PG; Wreford NG; Robertson DM; McLachlan RI
Endocrinology; 1996 Jul; 137(7):2703-10. PubMed ID: 8770889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]